Robyn Temple-Smolkin (@robyn_temple) 's Twitter Profile
Robyn Temple-Smolkin

@robyn_temple

Senior Director, Clinical & Scientific Affairs; Director, Guideline Development at @AMPath. MBA, PhD, HCLD(ABB). Tweets are my own; RTs ≠ endorsements

ID: 2463332676

calendar_today25-04-2014 15:02:17

2,2K Tweet

884 Followers

1,1K Following

Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

Resource alert: The AMP Clinical Practice Committee has assembled a list of available resources on H5N1 at amp.org/clinical-pract…. Please check back frequently for updates. Image: flickr.com/photos/niaid/5…

Resource alert: The AMP Clinical Practice Committee has assembled a list of available resources on H5N1 at amp.org/clinical-pract…. 

Please check back frequently for updates.

Image: flickr.com/photos/niaid/5…
Atul Butte (@atulbutte) 's Twitter Profile Photo

What a thrill it was last month to win both the American College of Medical informatics ACMI Morris F. Collen Award of Excellence (amia.org/communities/ac…) and the Association for Molecular Pathology Association for Molecular Pathology Award for Excellence in Molecular Diagnostics (amp.org/membership/awa…)!

The Journal of Molecular Diagnostics (@jmdiagn) 's Twitter Profile Photo

#LegacyContent: Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of Association for Molecular Pathology and CAPathologists. Free in the #OpenArchive: jmdjournal.org/article/S1525-…

Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

.Association for Molecular Pathology is now a member organization of AJCC, which "provides worldwide leadership in the development, promotion and maintenance of evidence-based systems for the classification and management of cancer." facs.org/quality-progra… (cc: ACS Cancer Programs )

Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

Not sure what your lab should be doing in light of the FDA's final rule on laboratory-developed testing procedures? We've put together a webpage with a ton of resources to help you at each stage. Check it out and share it with others who need it: amp.org/advocacy/amp-v…

Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

Free webinar on Jan. 30: "Germline Testing in Cancer Patients: Molecular Diagnostic Considerations and Clinical Implications." It'll feature speaker Diana Mandelker of Memorial Sloan Kettering Cancer Center and provide continuing-education credit: educate.amp.org/local/catalog/…

Free webinar on Jan. 30: "Germline Testing in Cancer Patients: Molecular Diagnostic Considerations
and Clinical Implications." It'll feature speaker Diana Mandelker of <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> and provide continuing-education credit: educate.amp.org/local/catalog/…
Robyn Temple-Smolkin (@robyn_temple) 's Twitter Profile Photo

Help support Association for Molecular Pathology volunteers working with AJCC to provide #precisionmedicine expertise supporting best practices for #oncology #patientcare? Now there’s a New Year’s resolution I’m happy to keep!

National Institute of Standards and Technology (@nist) 's Twitter Profile Photo

NIST has developed a reference material to support the production of diagnostic tests for the bird flu (H5N1). This nonhazardous genetic material will enhance the nation’s response to outbreaks of disease and ensure companies’ quality control. Read more: nist.gov/news-events/ne…

NIST has developed a reference material to support the production of diagnostic tests for the bird flu (H5N1). This nonhazardous genetic material will enhance the nation’s response to outbreaks of disease and ensure companies’ quality control. Read more: nist.gov/news-events/ne…
Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

We convened a working group to update the guideline for classification, annotation, interpretation and reporting of somatic sequence variants published in 2017. The working group seeks comments on its draft recommendations. Read them and submit a comment: amp.org/clinical-pract…

We convened a working group to update the guideline for classification, annotation, interpretation and reporting of somatic sequence variants published in 2017. The working group seeks comments on its draft recommendations. Read them and submit a comment: amp.org/clinical-pract…
Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

We're going to be at USCAP's annual meeting this weekend! Swing by booth 1004 to meet our membership manager, Jocelyn Friedrich; get your hands on some "Molecular in My Pocket" reference cards; and find out what being a member of Association for Molecular Pathology can mean for you. #USCAP2025

We're going to be at  <a href="/TheUSCAP/">USCAP</a>'s annual meeting this weekend! Swing by booth 1004 to meet our membership manager,  Jocelyn Friedrich; get your hands on some "Molecular in My Pocket" reference cards; and find out what being a member of <a href="/AMPath/">Association for Molecular Pathology</a> can mean for you. #USCAP2025
Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

🔬 Dive into #bioinformatics challenges with our "Next-Generation Bioinformatics" certificate program! This online training examines complex genomic anomalies in NGS testing. 🌟 Members save 25%! Enroll ➡️ educate.amp.org/local/catalog/…

🔬 Dive into #bioinformatics challenges with our "Next-Generation Bioinformatics" certificate program! This online training examines complex genomic anomalies in NGS testing. 🌟 Members save 25%!  Enroll ➡️ educate.amp.org/local/catalog/…
Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

We're at USCAP's annual meeting this weekend! Swing by booth 1004 to meet our membership manager, Jocelyn Friedrich; get your hands on some "Molecular in My Pocket" reference cards; and find out what being a member of Association for Molecular Pathology can mean for you. #USCAP2025

We're at <a href="/TheUSCAP/">USCAP</a>'s annual meeting this weekend! Swing by booth 1004 to meet our membership manager,  Jocelyn Friedrich; get your hands on some "Molecular in My Pocket" reference cards; and find out what being a member of <a href="/AMPath/">Association for Molecular Pathology</a> can mean for you. #USCAP2025
Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

At our AMP Middle East meeting in Abu Dhabi, Somak Roy (Somak Roy, MD)will give two presentations, one about what clinical bioinformaticians need to know and one about in silico resources for NGS bioinformatics pipeline validation. See all speakers: ampmiddleeast25.amp.org/speakers/

At our AMP Middle East meeting in Abu Dhabi, Somak Roy (<a href="/roysomak4/">Somak Roy, MD</a>)will give two presentations, one about what clinical bioinformaticians need to know and one about in silico resources for NGS bioinformatics pipeline validation. 

See all speakers: ampmiddleeast25.amp.org/speakers/
Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

Today's the last day to secure early-bird pricing on our live online Molecular Genetic Pathology Review Course in May! This course will include lectures, case studies, live Q&A sessions and in-depth discussions. Learn more and register: amp.org/events/molecul…

Today's the last day to secure early-bird pricing on our live online Molecular Genetic Pathology Review Course in May!  This course will include lectures, case studies, live Q&amp;A sessions and in-depth discussions. Learn more and register:  amp.org/events/molecul…
Association for Molecular Pathology (@ampath) 's Twitter Profile Photo

🚨 Big news: The U.S. District Court has ruled in our favor, thwarting the FDA’s attempt to impose excessive regulations on laboratory-developed testing procedures (LDTs). This is a win for labs, patients and innovation! Ruling and opinion: amp.org/advocacy/amp-v…

🚨 Big news: The U.S. District Court has ruled in our favor, thwarting the FDA’s attempt to impose excessive regulations on laboratory-developed testing procedures (LDTs). This is a win for labs, patients and innovation! Ruling and opinion: amp.org/advocacy/amp-v…